Institutional Knowledge Map (KMap)
Map
Services
How To Use
About
Toggle theme
Loading...
Menu
Ryan Akhbari
Clinical Research Coordinator, Senior
Liver Research Institute
Map Page
Research Area
clinical trial,
liver disease,
alpha-1 antitrypsin,
treatment,
safety,
drug therapy,
biomarker,
immunology
Grants
(2)
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Fazirsiran in the Treatment of Alpha-1 Antitrypsin Deficiency?associated Liver Disease With Metavir
Active
·
2023
·
$0 / $1.6M
·
External
clinical trial,
liver disease,
alpha-1 antitrypsin,
treatment,
safety
TRANSFORM: A 52-week, Randomized, Placebo-controlled, Double-blind, Adaptive Phase 2b/3 Trial of Setanaxib with a 52-week Extension Phase in Patients with Primary Biliary Cholangitis (PBC) and Elevate
Active
·
2023
·
$0 / $641.6K
·
External
clinical trial,
drug therapy,
liver disease,
biomarker,
immunology
Collaborations
(13)
Nathan Cherrington
Mutual work: 1 Proposal
Collaboration Details
Dean Billheimer
Mutual work: 1 Proposal
Collaboration Details
Geoffrey Block
Mutual work: 5 Proposals﹒2 Grants
Collaboration Details
Catharine Smith
Mutual work: 1 Proposal
Collaboration Details
Kirsten Anderson
Mutual work: 2 Grants﹒4 Proposals
Collaboration Details
Page 1 of 3
Previous page
Next page
10+ Collaborators
$0 / $2.2M Funding